G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 1 057.2 INR 2.9% Market Closed
Market Cap: 129.5B INR
Have any thoughts about
Glenmark Life Sciences Ltd?
Write Note

Glenmark Life Sciences Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glenmark Life Sciences Ltd
Total Current Assets Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
M
MANKIND

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Total Current Assets
â‚ą18.5B
CAGR 3-Years
10%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Current Assets
â‚ą194.4B
CAGR 3-Years
14%
CAGR 5-Years
9%
CAGR 10-Years
13%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Current Assets
â‚ą434.3B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
9%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Total Current Assets
â‚ą115B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
13%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Current Assets
â‚ą56.1B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
5%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Current Assets
â‚ą65.7B
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Glenmark Life Sciences Ltd's Total Current Assets?
Total Current Assets
18.5B INR

Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Total Current Assets amounts to 18.5B INR.

What is Glenmark Life Sciences Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
15%

Over the last year, the Total Current Assets growth was 0%. The average annual Total Current Assets growth rates for Glenmark Life Sciences Ltd have been 10% over the past three years , 15% over the past five years .

Back to Top